Login to get the latest articles, videos,
gallery, and a lot more…
Email
Google
Facebook
T Derma 0.1% Ointment
Product introduction
T Derma 0.1% Ointment is used to treat eczema (atopic dermatitis). It works by suppressing the activity of certain immune cells that cause inflammation (redness and swelling) of the skin.
This relieves itching and improves rashes in atopic dermatitis.
T Derma 0.1% Ointment is used for external use. It should be used 2-4 times a day on the affected area or use it as suggested by the doctor.
It should be applied slowly and evenly to the skin until it is rubbed in. You should not use it too often and you should not cover the treated area with a bandage or plaster.
You must inform your doctor if there’s no improvement even after two weeks of treatment or if the skin gets worse.
Use of this medicine may cause some common side effects like erythema, headache, inflammation of hair follicle, and application site reaction like burning, irritation, itching, and redness.
This medicine is not normally recommended during pregnancy or while breastfeeding unless it is clearly needed.
- Treatment of Atopic dermatitis
Usage of T Derma 0.1% Ointment
Side effects of T Derma 0.1% Ointment
- Application site reactions (burning, irritation, itching and redness)
- Headache
- Hair follicle inflammation
How to use T Derma 0.1% Ointment
This medicine is for external use only. Use it in the dose and duration as advised by your doctor. Check the label for directions before use. Clean and dry the affected area and gently massage the ointment.
Functionality of T Derma 0.1% Ointment
T Derma 0.1% Ointment is an immunosuppressant. It works by suppressing the activity of certain immune cells that cause inflammation (redness and swelling) of the skin. This relieves itching and improves rashes in atopic dermatitis.
Safety Advice
Alcohol
No interaction found/established
Pregnancy
T Derma 0.1% Ointment may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
T Derma 0.1% Ointment is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Driving
No interaction found/established
Kidney
No interaction found/established
Liver
No interaction found/established
The information provided is for educational and informational purposes only. While we strive to ensure accuracy and completeness, this content should not be considered a substitute for professional medical advice, diagnosis, or treatment. Medicines, their salts, uses, and potential side effects listed are general references and may not apply to every case. Self-prescribing or altering medication based on this information without consulting a qualified healthcare professional can lead to serious health risks. Always seek the advice of a doctor or a licensed medical practitioner before starting, changing, or discontinuing any medication. Health and Me or Times Network do not assume responsibility for any consequences arising from reliance on this content. In case of any health concerns, side effects, or emergencies, please contact a medical professional immediately.
- Burkhart C, Morrell D, Goldsmith L. Dermatological Pharmacology. In Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s The Pharmacological Basis of Therapeutics. 12th ed. New York, New York McGraw-Hill Medical; 2011. p. 1822.
- Lake DF, Briggs AD, Akporiaye ET. Immunopharmacology. In Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India Tata McGraw Hill Education Private Limited; 2009. p. 972.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA Wolters Kluwer Health; 2015. pp. 1305-309.
- Tacrolimus monohydrate. Hurley, Berkshire Leo Laboratories Limited; 2002 [revised 30 Jun. 2018]. [Accessed 17 Apr. 2019] (online)
- Central Drugs Standard Control Organisation (CDSCO). [Accessed 06 Apr. 2019] (online)
- Tacrolimus [Prescribing Information]. Dublin 12, Ireland LEO Laboratories Ltd.; 2022. [Accessed 01 Aug. 2023]. (online)
Name: Zargan Healthcare
Address: SCO 42, Back Side Entry, Sec. 47-D, Chandigarh-160047(UT)
A licensed vendor partner from your nearest location will deliver the product. Once the pharmacy accepts your order, the details of the pharmacy will be shared with you. Acceptance of your order is based on the validity of your doctor's ℞ and the availability of this medicine.
Newsletter
Stay Tuned
stay healthy